⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALGS News
Aligos Therapeutics, Inc. Common Stock
Non-Alcoholic Steatohepatitis (NASH/MASH) - Drug Pipeline Insight 2026 | 75+ Candidates Across 70+ Companies Drive Licensing and Investment Opportunities
globenewswire.com
NVO
VKTX
GSK
ALGS
Remix Therapeutics™ Appoints Michael Landsittel to Board of Directors
globenewswire.com
ALGS
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
globenewswire.com
ALGS
Form 8-K
sec.gov
ALGS
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
globenewswire.com
ALGS
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
globenewswire.com
ALGS
Form 8-K
sec.gov
ALGS
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
globenewswire.com
ALGS
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
globenewswire.com
ALGS
Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
ALGS